Hinge Health, Inc. (HNGE) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — HNGE

Balance Sheet

(in billions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025
Cash & Equivalents	0.29	0.19	0.26	0.24
Short-term Investments	--	--	0.22	0.18
Accounts Receivable	0.13	0.11	0.09	0.10
Inventory	0.02	0.01	0.01	0.01
Total Current Assets	0.64	0.54	0.66	0.60
Property, Plant & Equipment	0.01	0.01	0.01	0.01
Goodwill	0.06	0.06	0.06	0.06
Intangible Assets	0.00	0.00	0.00	0.00
Total Non-current Assets	0.02	0.02	0.02	0.02
Total Assets	0.83	0.73	0.77	0.69
Accounts Payable	0.06	0.07	0.05	0.03
Total Current Liabilities	0.48	0.41	0.36	0.31
Total Non-current Liabilities*	0.00	0.00	0.00	0.01
Total Liabilities	0.48	0.42	0.36	0.32
Retained Earnings	(0.97)	(1.02)	(1.08)	(1.08)
Total Stockholder Equity	0.34	0.11	0.21	0.17

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025
Total Revenue	212.82	182.31	170.73	154.21	139.10
Cost of Revenue	28.87	28.07	26.70	28.01	41.34
Gross Profit	183.95	154.23	144.03	126.20	97.76
Research & Development	34.06	30.34	32.76	31.92	279.96
Selling, General & Admin	28.04	23.02	24.53	36.85	251.24
Total Operating Expenses	143.51	122.16	116.77	132.29	678.43
Operating Income	40.44	32.07	27.26	(6.09)	(580.67)
Pretax Income	44.43	35.94	32.22	(1.64)	(575.98)
Tax Provision	0.74	0.81	0.12	0.21	(0.33)
Net Income	43.69	35.13	32.10	(1.84)	(575.65)
Basic EPS	0.55	0.43	2.11	(0.02)	(13.10)
Diluted EPS	0.52	0.41	2.11	(0.02)	(13.10)

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025
Operating Cash Flow	101.41	43.08	63.89	82.40	25.15
Capital Expenditures	0.12	0.08	0.41	0.05	0.25
Free Cash Flow*	101.29	43.00	63.49	82.35	24.90
Investing Cash Flow	28.62	48.08	(37.70)	(58.76)	(17.31)
Financing Cash Flow	(30.48)	(112.85)	(79.54)	0.53	(71.45)

* Derived from reported values